Xenobiotics in Chemical Carcinogenesis Xenobiotics in Chemical Carcinogenesis

Xenobiotics in Chemical Carcinogenesis

Translational Aspects in Toxicology

    • 159,99 €
    • 159,99 €

Beschreibung des Verlags

Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology covers the translational toxicology of xenobiotics substances in carcinogenesis by explaining the toxicokinetic and toxicodynamic, toxicogenomic, biotransformation, and resistance mechanisms in the human body. The book begins with a historical review and link to future prospects for chemical carcinogenesis. It discusses major environmental xenobiotics and their risks in inducing cancer, along with content on toxic xenobiotics and their routes of exposure in humans, the role of xenobiotic metabolism in carcinogenesis, and the toxicokinetic and toxicodynamic of xenobiotics in cancer development.

Lastly, the book explores current achievements such as using toxicogenomics for predicting the carcinogenicity of xenobiotic substances and the challenges posed by carcinogenic xenobiotic substances when examining preventive methods, diagnosis, and the development of anticancer drugs for specific toxicants. Covers the exposure and transmission of various toxic xenobiotics substances, including nanomaterials, to humans and their interaction with specific tissues in precipitating the development of cancers Unravels the toxicokinetic and toxicodynamic processes of toxic xenobiotics in bioaccumulation Examines the genetic aberrations in cancer genomes by genetic-environmental interactions in carcinogenesis Explains the biotransformation mechanisms of toxic xenobiotics by gut microbes in humans

GENRE
Wissenschaft und Natur
ERSCHIENEN
2022
17. Februar
SPRACHE
EN
Englisch
UMFANG
328
Seiten
VERLAG
Elsevier Science
GRÖSSE
11,6
 MB

Mehr Bücher von Akhileshwar Kumar Srivastava PhD, Dhruv Kumar, Divya Singh & Rajesh Kumar Singh

Drug-delivery systems of phytochemicals as therapeutic strategies in cancer therapy Drug-delivery systems of phytochemicals as therapeutic strategies in cancer therapy
2023
Evolutionary Diversity as a Source for Anticancer Molecules Evolutionary Diversity as a Source for Anticancer Molecules
2020